The interferon-α regulation of interferon regulatory factor 1 (IRF-1) and IRF-2 has therapeutic implications in carcinoid tumors

This publication has 22 references indexed in Scilit:

• Expression of p68 protein kinase and its prognostic significance during IFN-α therapy in patients with carcinoid tumours
  European Journal Of Cancer, 1998
• Targeted disruption of the mouse phospholipase C β3 gene results in early embryonic lethality
  FEBS Letters, 1998
• Activation of multiple growth regulatory genes following inducible expression of IRF-1 or IRF/RelA fusion proteins
  Oncogene, 1997
• Activation of a cell-cycle-regulated histone gene by the oncogenic transcription factor IRF-2
  Nature, 1995
• Regulation of the interferon system and cell growth by the IRF transcription factors
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1995
• An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes
  Nature, 1995
• Suppression of c-myc or fosB-induced cell transformation by the transcription factor IRF-1
  Cancer Letters, 1994
• The Role of Interferons in the Management of Carcinoid Tumors
  Acta Oncologica, 1991
• Interferon-induced enhancement of 2',5'-oligoadenylate synthetase in mid-gut carcinoid tumours
  The Lancet, 1990
• Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes
  Published by Elsevier ,1989